Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000032

Options or other derivatives

  • Chief Executive Officer acquired 217,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-04-08 Grant or award : show line 1 in the form Stock options (right to buy) +170,000 170,000 D
2022-04-08 Grant or award : show line 2 in the form Restricted stock units +47,800 47,800 D
Loading xslF345X03/wf-form4_164979367185851.xml…